Doximity, Inc. (DOCS) Misses Q4 EPS by 2c, Beats on Revenue; Offers FY26 Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Doximity Announces Fourth Quarter and Fiscal Year 2026 Financial Results
May 13, 2026 4:01 PM EDTFiscal year 2026 total revenues of $644.9 million, up 13% year-over-year
Fiscal year 2026 operating cash flows of $326.5 million, up 19% year-over-year
Fiscal year 2026 free cash flow of $317.5 million, up 19% year-over-year
SAN FRANCISCO--(BUSINESS WIRE)-- Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2026 fourth quarter and fiscal year ended March 31, 2026.
Were thrilled to announce that we reached a new engagement record of over 800,000 active prescribers using our... More
